Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Significant weight changes, appetite shifts, and the experience of treatment can affect mood for some people, in either direction
Despite the positive results, due to the limited number of included studies, further randomized controlled trials are needed to investigate the safety and efficacy of SGLT2i and GLP-1RAs as first-line treatment options for patients with T2DM at low cardiovascular disease risk, particularly when compared to metformin
Understanding this link could lead to big advances in health care
Journal of Clinical Endocrinology & Metabolism
US$ 20.29
US$ 24.55
US$ 21.04
